Constrictive pericarditis laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Constrictive pericarditis}}
{{Constrictive pericarditis}}
{{CMG}}
{{CMG}}; {{AE}} {{Hudakarman}}


==Overview==
==Overview==
Line 25: Line 25:
*Proteinuria (nephrotic range)
*Proteinuria (nephrotic range)
*Elevated sedimentation rate (ESR), C-reactive protein (CRP) level (postpericardiotomy syndrome)
*Elevated sedimentation rate (ESR), C-reactive protein (CRP) level (postpericardiotomy syndrome)
*Brain natriuretic peptide (BNP), mildly increased (<150 ng/L).
*Brain natriuretic peptide (BNP), mildly increased (<150 ng/L)<ref name="pmid159366242">{{cite journal| author=Leya FS, Arab D, Joyal D, Shioura KM, Lewis BE, Steen LH et al.| title=The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy. | journal=J Am Coll Cardiol | year= 2005 | volume= 45 | issue= 11 | pages= 1900-2 | pmid=15936624 | doi=10.1016/j.jacc.2005.03.050 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15936624  }}</ref>
*Antinuclear antibody (ANA) or rheumatoid factor (RF) (associated collagen vascular disorder)
*Antinuclear antibody (ANA) or rheumatoid factor (RF) (associated collagen vascular disorder)
*Purified protein derivative (PPD) skin test (TB)
*Purified protein derivative (PPD) skin test (TB)

Latest revision as of 18:25, 27 December 2019

Constrictive Pericarditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Constrictive Pericarditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Constrictive pericarditis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Constrictive pericarditis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Constrictive pericarditis laboratory findings

CDC on Constrictive pericarditis laboratory findings

Constrictive pericarditis laboratory findings in the news

Blogs on Constrictive pericarditis laboratory findings

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Constrictive pericarditis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Huda A. Karman, M.D.

Overview

Constrictive pericarditis lab findings can show evidence of congestive heart failure, or associated protein losing enteropathy, nephrotic syndrome, and LFT abnormalities consistent with hepatic congestion and chylous ascites

Laboratory findings

  • Complete blood count (CBC)
  • Leukocytosis
  • Leukopenia
    • Malignancy and chemotherapeutic agents use
  • Hyponatremia or pseudohyponatremia
  • Contraction alkalosis (hypochloremia with hypercarbia)
  • Elevation of blood urea nitrogen (BUN) levels f
  • Serum creatinine levels are observed
  • Arterial blood gas measurement
  • Metabolic acidosis (ie, low pH and low bicarbonate),
  • Compensatory respiratory alkalosis (ie, decreased partial pressure of carbon dioxide
  • Elevated transaminase levels
  • Hypoalbuminemia (a protein-losing enteropathy (PLE)
  • Proteinuria (nephrotic range)
  • Elevated sedimentation rate (ESR), C-reactive protein (CRP) level (postpericardiotomy syndrome)
  • Brain natriuretic peptide (BNP), mildly increased (<150 ng/L)[1]
  • Antinuclear antibody (ANA) or rheumatoid factor (RF) (associated collagen vascular disorder)
  • Purified protein derivative (PPD) skin test (TB)

References

  1. Leya FS, Arab D, Joyal D, Shioura KM, Lewis BE, Steen LH; et al. (2005). "The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy". J Am Coll Cardiol. 45 (11): 1900–2. doi:10.1016/j.jacc.2005.03.050. PMID 15936624.